Chloroquine
(Synonyms: 氯喹) 目录号 : GC19549氯喹是一种抗疟疾和抗炎剂,广泛用于治疗疟疾和类风湿性关节炎。
Cas No.:54-05-7
Sample solution is provided at 25 µL, 10mM.
-
Related Biological Data
RABV-M blocks the autophagic flux. (A) RABV-M-FLAG was expressed in N2a cells for the indicated time periods, and cell lysates were analyzed by WB. (B) N2a cells were transfected with RABV-M-FLAG for 12 h and then treated with/without chloroquine (CQ, 2 μM) for 24 h. Cell lysates were analyzed by WB.
N2a cells were transfected with RABV-M-FLAG for 12 h and then treated with/without chloroquine (CQ, 2 μM, GlpBio) for 24 h.
Autophagy just-accepted (2024). PMID: 38566321 IF: 13.3003 -
Related Biological Data
Hypoxia-inducible factor-1α-mediated mitophagy prevented bevacizumab-induced ROS accumulation and apoptosis in vitro: Cultured 661W photoreceptors, MIO-M1 Müller cells, and HUVECs were treated with bevacizumab or CQ alone.
Chloroquine (10 mg/kg, GlpBio) was given 1 h prior to bevacizumab vitreous injection and then every 24 h until sacrifice.
Front Cell Dev Biol (2021): 3048. PMID: 34790659 IF: 6.684
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Chloroquine is used as an antimalarial drug and also functions to increase sensitivity of tumor cells to radiation and chemotherapy via inducing autophagy [1].
Chloroquine has been reported as an adjuvant for radiation and chemotherapy for inducing cell autophagy to anti-cancer cells proliferation or metastasis [2]. The mechanism of chloroquine diphosphate inducing cells autophagy is arresting cells in G1, up-regulates the expression of p27 and p53 while down-regulates the expression of CDK2 and cyclin D1 [3].
Apart from anti-malarial, chloroquine also has long been reported functioning in cell apoptosis. Pretreated CNE-2 human nasopharyngeal carcinoma cells with chloroquine enhanced ionizing radiation induced cell apoptosis via increasing cells autophagic ratio [4]. When treated with mouse breast cancer 4T1 cells, chloroquine treatment inhibited cellular proliferation and viability which resulted in cells apoptosis in a time- and dose- dependent manner [2]. In human colon cancer DLD-1 cells, combination of 5-FU and chloroquine could inhibit cells proliferation via inducing autophagy [3].
In mouse model with 4T1 cells subcutaneous xenograft, chloroquine treatment significantly inhibited tumor growth and tumor cells metastasis to the lung, thus enhanced the mice survival [2]. In BALB/c mice injected with colon26 cells subcutaneously, chloroquine cooperated with 5-FU significantly enhanced the inhibition of tumor growth induced by 5-FU through increasing the ratio of apoptotic cells [5].
References:
[1]. Gewirtz, D.A., An autophagic switch in the response of tumor cells to radiation and chemotherapy. Biochem Pharmacol, 2014. 90(3): p. 208-11.
[2]. Jiang, P.D., et al., Antitumor and antimetastatic activities of chloroquine diphosphate in a murine model of breast cancer. Biomed Pharmacother, 2010. 64(9): p. 609-14.
[3]. Choi, J.H., et al., Chloroquine enhances the chemotherapeutic activity of 5-fluorouracil in a colon cancer cell line via cell cycle alteration. APMIS, 2012. 120(7): p. 597-604.
[4]. Zhou, Z.R., et al., Poly(ADP-ribose) polymerase-1 regulates the mechanism of irradiation-induced CNE-2 human nasopharyngeal carcinoma cell autophagy and inhibition of autophagy contributes to the radiation sensitization of CNE-2 cells. Oncol Rep, 2013. 29(6): p. 2498-506.
[5]. Sasaki, K., et al., Resistance of colon cancer to 5-fluorouracil may be overcome by combination with chloroquine, an in vivo study. Anticancer Drugs, 2012. 23(7): p. 675-82.
Cas No. | 54-05-7 | SDF | |
别名 | 氯喹 | ||
分子式 | C18H26ClN3 | 分子量 | 319.8721 |
溶解度 | 64 mg/mL (200.08 mM) in DMSO, 64 mg/mL (200.08 mM) in Ethanol, Insoluble in Water | 储存条件 | 4°C, protect from light |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 3.1262 mL | 15.6312 mL | 31.2625 mL |
5 mM | 0.6252 mL | 3.1262 mL | 6.2525 mL |
10 mM | 0.3126 mL | 1.5631 mL | 3.1262 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。